Mirza Ali Munir, Muratov Zhanibek, Kudaibakovich Tukhvatshin Rustam, Ramanovich
{"title":"COVID-19幸存者的间歇性常压缺氧疗法：一种有希望康复的方法","authors":"Mirza Ali Munir, Muratov Zhanibek, Kudaibakovich Tukhvatshin Rustam, Ramanovich","doi":"10.51582/interconf.19-20.02.2024.038","DOIUrl":null,"url":null,"abstract":"This groundbreaking study delves into the transformative potential of Intermittent Normobaric Hypoxia Therapy (INHT) in a targeted cohort of 50 young adult COVID-19 survivors, aged 18 to 24 years. Through comprehensive pre- and post-INHT spirometry assessments, our research uncovers the nuanced respiratory benefits of this innovative therapy. The results showcase significant improvements in key spirometry parameters, emphasizing INHT's pivotal role in restoring lung function and fostering holistic respiratory well-being post-COVID-19","PeriodicalId":514427,"journal":{"name":"InterConf","volume":"244 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intermittent normobaric hypoxia therapy for COVID-19 survivors: a promising approach to recovery\",\"authors\":\"Mirza Ali Munir, Muratov Zhanibek, Kudaibakovich Tukhvatshin Rustam, Ramanovich\",\"doi\":\"10.51582/interconf.19-20.02.2024.038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This groundbreaking study delves into the transformative potential of Intermittent Normobaric Hypoxia Therapy (INHT) in a targeted cohort of 50 young adult COVID-19 survivors, aged 18 to 24 years. Through comprehensive pre- and post-INHT spirometry assessments, our research uncovers the nuanced respiratory benefits of this innovative therapy. The results showcase significant improvements in key spirometry parameters, emphasizing INHT's pivotal role in restoring lung function and fostering holistic respiratory well-being post-COVID-19\",\"PeriodicalId\":514427,\"journal\":{\"name\":\"InterConf\",\"volume\":\"244 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"InterConf\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51582/interconf.19-20.02.2024.038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"InterConf","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51582/interconf.19-20.02.2024.038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Intermittent normobaric hypoxia therapy for COVID-19 survivors: a promising approach to recovery
This groundbreaking study delves into the transformative potential of Intermittent Normobaric Hypoxia Therapy (INHT) in a targeted cohort of 50 young adult COVID-19 survivors, aged 18 to 24 years. Through comprehensive pre- and post-INHT spirometry assessments, our research uncovers the nuanced respiratory benefits of this innovative therapy. The results showcase significant improvements in key spirometry parameters, emphasizing INHT's pivotal role in restoring lung function and fostering holistic respiratory well-being post-COVID-19
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
